News

February 2012

Prometheus Announces New Chief Commercial Officer

Friday 3 Feb, 2012

Endo Pharmaceuticals to Announce Fourth Quarter and Full Year 2011 Financial Results on February 24, 2012

Friday 3 Feb, 2012

Federal Court Dismisses Whistleblower Lawsuit Against Millennium Laboratories

Friday 3 Feb, 2012

Genomic Health Presents Results Furthering Understanding of Biology of Prostate Cancer at the 2012 Genitourinary Cancers Symposium

Friday 3 Feb, 2012

Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide Inhibitor, IDX184

Friday 3 Feb, 2012

Study Published in Neuro-Oncology Journal Shows Brain Tumor Eradication and Prolonged Survival in Mice Treated With Toca 511 and 5-FC

Friday 3 Feb, 2012

Michael Kaufmann of Cardinal Health Named as the Healthcare Businesswomen's Association's 2012 Honorable Mentor

Friday 3 Feb, 2012

Aeterna Zentaris Reports Updated Phase 1 Trial Results for AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer at ASCO GCS Meeting

Friday 3 Feb, 2012

Medicago Announces Investment in Quebec City Pilot Production Facility

Friday 3 Feb, 2012

Biodel to Report First Quarter Fiscal Year 2012 Financial Results on February 8, 2012

Friday 3 Feb, 2012

IRIDEX and Cutera Close Acquisition of IRIDEX' Aesthetic Business Unit

Friday 3 Feb, 2012

The Ensign Group Acquires Reno Assisted Living Facility

Friday 3 Feb, 2012

Team Led By Scripps Research Scientists Demonstrates Effective New 'Biopsy in a Blood Test' to Detect Cancer

Friday 3 Feb, 2012

Perrigo Company Announces Quarterly Dividend

Thursday 2 Feb, 2012

Who Will Be The 2012 Next-Generation Pharmacist™?

Thursday 2 Feb, 2012

Auxogyn Completes $20 Million In Series A Funding

Thursday 2 Feb, 2012

Blue Cross and Blue Shield of Florida Introduces First-of-its-Kind Patient Centered Medical Home Program

Thursday 2 Feb, 2012

Marina Biotech, Inc. Joins OTCQX

Thursday 2 Feb, 2012

Bayer Initiates Expanded Access Program for Investigational Compound Radium-223 Chloride

Thursday 2 Feb, 2012

CryoLife Announces Release Date and Teleconference Call Details for 2011 Fourth Quarter and Year End Financial Results

Thursday 2 Feb, 2012

Hybrid Fuels, Inc. Announces FDA Approved Lab Selection for Azul Instant™ - "Be Ready in an Instant"

Thursday 2 Feb, 2012

BioParadox Announces Partnership with Fogarty Institute for Innovation

Thursday 2 Feb, 2012

Clinical Data on OGX-427 Presented at the ASCO 2012 Genitourinary Cancers Symposium Provide Ongoing Evidence of Hsp27 as a Potential Therapeutic Target in Advanced Prostate Cancer

Thursday 2 Feb, 2012

Phase 1 Study of OGX-427 Presented at the ASCO 2012 Genitourinary Cancers Symposium Shows Early Evidence of Activity in Bladder Cancer

Thursday 2 Feb, 2012

Ronnie Andrews Joins Life Technologies as President, Medical Sciences

Thursday 2 Feb, 2012

Discovery Labs Cleared to Market AFECTAIR in U.S.

Thursday 2 Feb, 2012

Insero Health Closes Initial Round of Financing and Signs Exclusive Licenses With Harvard and Yale

Thursday 2 Feb, 2012

Mylan Receives Tentative FDA Approval for Generic Version of Lipitor®

Thursday 2 Feb, 2012

Nuvo Research announces launch of Synera® in the U.S.

Thursday 2 Feb, 2012

Kensey Nash Reports Second Quarter Fiscal Year 2012 Financial Results

Thursday 2 Feb, 2012

Bayer Expands Its Hemophilia Leadership Development Program

Thursday 2 Feb, 2012

Cardinal Health Reports Second-Quarter Results

Thursday 2 Feb, 2012

Syneron Announces New Ground Breaking evolastin™ Procedure

Thursday 2 Feb, 2012

Delcath Announces First European Chemosat Procedures

Thursday 2 Feb, 2012

AstraZeneca Fourth Quarter and Full-Year 2011 Results - Interviews

Thursday 2 Feb, 2012

Winner Medical Group Inc. to Host First Quarter 2012 Earnings Conference Call on Thursday, February 9, 2012 at 08:00 p.m. EST

Thursday 2 Feb, 2012

EUSA Pharma Acquires Development and Commercialization Rights to ASPAREC® for Treatment of Acute Lymphoblastic Leukemia from Alizé Pharma

Thursday 2 Feb, 2012

ResearchMoz: Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Thursday 2 Feb, 2012

Catheters Market - Global Market to Increase at a CAGR of 8.7% & reach $32.1 Billion by 2016

Thursday 2 Feb, 2012

Preliminary Figures for 2011: Sartorius Grows at Double-Digit Rates and Boosts Operating Earnings by More Than 30%

Thursday 2 Feb, 2012

ThromboGenics Announces That the FDA Intends to Grant Ocriplasmin Priority Review

Thursday 2 Feb, 2012

In Honor of American Heart Month, Joy Behar & Daughter Eve Call on Women to Take the ProHeart Pledge on Facebook

Wednesday 1 Feb, 2012

Apgar & Associates and ID Experts Form Partnership; "Mock OCR HIPAA Compliance Audits" Prepare Healthcare Organizations for Audits by Office for Civil Rights, Now Underway

Wednesday 1 Feb, 2012

ThermoGenesis Provides Update on Res-Q® Clinical Evaluations at Leading Stem Cell Therapy Conference

Wednesday 1 Feb, 2012

Roche Receives FDA Clearance for Test to Screen and Diagnose Chlamydia and Gonorrhea Infection in Symptomatic and Asymptomatic Patients

Wednesday 1 Feb, 2012

World's Leading Pharmaceutical Executives All Converging in Zurich, Switzerland on February 21-22, 2012 for Breakthrough Event

Wednesday 1 Feb, 2012

Cycle for Survival

Wednesday 1 Feb, 2012

Hill-Rom to Participate in the Leerink Swann 2012 Global Healthcare Conference

Wednesday 1 Feb, 2012

Partnership Between Lilly Diabetes and the American Diabetes Association to Send 89 Children to American Diabetes Association Diabetes Camps in 2012

Wednesday 1 Feb, 2012

Cyberonics to Report Fiscal Year 2012 Third Quarter Results and Host Conference Call on February 24, 2012

Wednesday 1 Feb, 2012

Shylendra Kumar Joins Pharmaceutical eConsulting

Wednesday 1 Feb, 2012

BG Medical Technologies Reveals 2012 Fiscal Year Strategy

Wednesday 1 Feb, 2012

Boston Scientific Announces First Implant and Market Launch of Promus Element™ Plus Stent System in Europe

Wednesday 1 Feb, 2012

Valeant Pharmaceuticals Acquires Probiotica in Brazil

Wednesday 1 Feb, 2012

Hybrid Fuels, Inc. Announces Breakthrough Benefits and Competitive Advantages of Azul Instant™ - "Be Ready in an Instant"

Wednesday 1 Feb, 2012

Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe

Wednesday 1 Feb, 2012

Direct Pet Health to Acquire Tenex Health

Wednesday 1 Feb, 2012

Cardinal Health Introduces Diagnostic Procedure Trays

Wednesday 1 Feb, 2012

Abbott to Present at Leerink Swann 2012 Global Healthcare Conference

Wednesday 1 Feb, 2012

Alchem International Opens Sales and Marketing Office in the U.S.

Wednesday 1 Feb, 2012

Codexis to Present at the Pacific Crest and Jefferies Conferences

Wednesday 1 Feb, 2012

Generex Announces Patent Award for its Core Vaccine Technologies in Japan

Wednesday 1 Feb, 2012

EUR 1.0 Million Grant Awarded to Exosome Diagnostics and Ludwig Maximilian University from German Federal Ministry for Education and Research to Develop Biofluid-Derived Exosome Diagnostics

Wednesday 1 Feb, 2012

ChromaDex® to Raise $10.85M in Sale of Common Stock

Wednesday 1 Feb, 2012

Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Wednesday 1 Feb, 2012

Galien Foundation Announces 2012 Awards Program For Best Biopharmaceutical Products and Best Medical Technology

Wednesday 1 Feb, 2012

AMRI CFO to Present at UBS 22nd Annual Global Healthcare Services Conference

Wednesday 1 Feb, 2012

Cardiocom® and Delta Health Technologies® Partner to Provide Telehealth Data Interface for Homecare and Hospice

Wednesday 1 Feb, 2012

EUR 1.0 Million Grant Awarded to Exosome Diagnostics and Ludwig Maximilian University from German Federal Ministry for Education and Research to Develop Biofluid-Derived Exosome Diagnostics

Wednesday 1 Feb, 2012

Leading Pharmaceutical Marketing Research and Consulting Company Introduces 'Intelligent Efficiency' Program

Wednesday 1 Feb, 2012

Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C (HCV) Patients Receiving Hemopurifier® Treatment Protocol

Wednesday 1 Feb, 2012

MedCath Corporation to Release First Quarter Results in Quarterly SEC Filing

Wednesday 1 Feb, 2012

Shire and Sangamo Collaborate to Develop Therapeutics for the Treatment of Hemophilia and Other Monogenic Diseases

Wednesday 1 Feb, 2012

Innocoll Enters CollaGUARD® Distribution Partnership With Flynn Pharma Ltd in the UK and Inresa Arzneimittel GmbH in Germany

Wednesday 1 Feb, 2012

Auxilium Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference

Wednesday 1 Feb, 2012

Henry Schein to Webcast Fourth Quarter 2011 Conference Call Wednesday, February 15, at 10:00 a.m. EST

Wednesday 1 Feb, 2012

BioMed Realty and Omeros Sign New 64,500 Square Foot Lease in Seattle

Wednesday 1 Feb, 2012

Belvidere Pharmacy, Custom Medicine Makers, Moves to New, and Even Better, Home

Wednesday 1 Feb, 2012

Shire and Sangamo Collaborate to Develop Therapeutics for the Treatment of Hemophilia and Other Monogenic Diseases

Wednesday 1 Feb, 2012

Elsevier and Russian Foundation of Basic Research Sign SciVerse ScienceDirect Access Agreement

Wednesday 1 Feb, 2012

ResearchMoz: Nanotech Enabled Drug Delivery Therapeutics Market Will be $136 Billion by the Year 2021: Nanotechnology in Drug Delivery: Global Markets

Wednesday 1 Feb, 2012

OncoSec President and CEO Contributes to Physicians News Digest

Wednesday 1 Feb, 2012

PAREXEL and ASAN Medical Center Establish Alliance to Accelerate Korea-based Drug Development and Commercialization Programs

Wednesday 1 Feb, 2012

The RARE List™ - You Must See it to Believe it!

Wednesday 1 Feb, 2012

Concord Medical Services Holdings Limited Engages Solebury Communications Group LLC to Establish a Strategic Investor Relations Program

Wednesday 1 Feb, 2012

Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists

Wednesday 1 Feb, 2012

MarketsandMarkets: Global Biomarkers Market worth $25.79 Billion by 2016

Wednesday 1 Feb, 2012